Shreni Zinzuwadia

Obesity Medicine in Newark, New Jersey

Practice Details

Address
150 Bergen St
Newark, NJ 07103
Geocoded location: 40.7414, -74.1918
Taxonomy
Obesity Medicine (Preventive Medicine)
Credential
M.D.
NPPES Enumeration
Listed with NPPES since 2008
Sole Proprietor
Yes
Provider Gender (NPPES)
Female
NPPES Record Updated
January 2026

About This Clinician

This clinician is enumerated under Obesity Medicine, a Preventive Medicine subspecialty focused specifically on the medical management of obesity — including behavioral counseling, nutrition, and pharmacotherapy such as GLP-1 receptor agonists. Obesity-medicine specialists in Newark are among the practices most likely to actively manage GLP-1 prescribing, though this registry entry does not confirm current prescribing practices.

Locally, this is 1 of 1 Obesity Medicine (Preventive Medicine) practice in Newark carrying this exact taxonomy in our directory.

What to expect at an Obesity Medicine visit

A first visit at an obesity-medicine practice generally centers on a medical work-up rather than a quick prescription. In broad terms, patients often encounter:

  • A weight and health history, BMI/body-composition review, and discussion of prior weight-loss attempts.
  • A conversation about treatment options — lifestyle changes, and where appropriate anti-obesity medications such as GLP-1 receptor agonists (semaglutide, tirzepatide).
  • Baseline labs (e.g. A1c, metabolic panel, lipids) to screen for diabetes and metabolic conditions before starting medication.
  • A cost and coverage discussion, since many commercial plans limit obesity-only GLP-1 coverage and may require prior authorization.

This is general guidance for obesity medicine practices, not a description of Shreni Zinzuwadia's specific protocol, services, or pricing. Confirm what a visit involves directly with the practice — 973-972-9261.

GLP-1 access in Newark, New Jersey

Adult obesity rate
28.7%
#42 of 50 states (CDC BRFSS)
Avg. compounded semaglutide
$224/mo
Typical New Jersey telehealth cash price
Medicaid GLP-1 coverage
Diabetes + obesity (with prior auth)
New Jersey Medicaid, obesity indication

About 28.7% of New Jersey adults have obesity (BMI 30+), ranking the state #42 of 50 (CDC BRFSS). Our directory currently lists 31 GLP-1-relevant clinics in Newark. If a cash-pay route makes more sense, compounded semaglutide through New Jersey telehealth averages about $224/mo — well below brand-name Wegovy or Zepbound.

Explore more New Jersey options on the best New Jersey GLP-1 providers page, browse every Newark listing in the Newark clinic directory, or read the New Jersey Medicaid GLP-1 coverage & prior-authorization guide.

Related Practices in Newark

Other Newark listings in the same directory tier:

Telehealth Alternative

Prefer not to visit in person? Licensed GLP-1 telehealth providers ship compounded semaglutide or tirzepatide directly to New Jersey addresses, often faster and at lower cash cost than an in-person visit and brand-name prescription. Featured New Jersey telehealth partners:

Featured Partners · Newark

Featured GLP-1 providers serving Newark

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

  1. Top pick

    Compounded from

    $249.99/mo

    Save $1,099.01/mo vs Wegovy
    Get started →
  2. Compounded from

    $99/mo

    Save $1,250/mo vs Wegovy
    Get started →
  3. Compounded from

    $199/mo

    Save $1,150/mo vs Wegovy
    Get started →
  4. Compounded from

    $147/mo

    Save $1,202/mo vs Wegovy
    Get started →
  5. 8.2

    Compounded from

    $149/mo

    Save $937/mo vs Zepbound
    Get started →
  6. Compounded from

    $249/mo

    Save $1,100/mo vs Wegovy
    Get started →

See more Newark options on the Newark clinic directory, our Newark GLP-1 telehealth page, or compare the best semaglutide providers nationwide.

Learn more about the medications most commonly prescribed by Newark obesity-medicine and endocrinology practices: Semaglutide and Tirzepatide.

Frequently Asked Questions

The CMS National Provider registry lists Shreni Zinzuwadia's specialty taxonomy but not the specific medications it prescribes or its current service menu. Shreni Zinzuwadia is listed under Obesity Medicine, a field where GLP-1 medications such as semaglutide (Wegovy, Ozempic) or tirzepatide (Zepbound, Mounjaro) are commonly prescribed — but whether this practice currently offers them isn't recorded in the registry. Call the practice at 973-972-9261 to confirm before booking.
According to its CMS National Provider registry (NPPES) record, Shreni Zinzuwadia's primary specialty on file is Obesity Medicine.
Shreni Zinzuwadia is located at 150 Bergen St, Newark, NJ 07103. The phone number listed in the registry is 973-972-9261. Its full record is public in the CMS National Provider registry under NPI 1629233275.
New-patient status isn't recorded in the CMS National Provider registry, so we can't confirm whether Shreni Zinzuwadia is currently accepting new patients. Call the practice at 973-972-9261 to confirm availability, cash-pay pricing, and whether the services you need are offered — this listing reflects the NPPES taxonomy on file and is not an endorsement.